22 results
treatment hivaids idsa opportunistic prevention diabetes dm2 agonists antibiotics glp1 mycobacterium summary acetaminophen antibiogram antiil6 aviumcomplex bartonella bartonellosis capsulatum chagas
GLP-1 Receptor Agonists - Pharmacology Summary Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... (ER version) ... side effects (e.g ... Receptor #Agonists #Pharmacology ... DM2 #diabetes #endocrinology
SGLT2 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors - Pharmacology ... hypovolemia) • GU infections ... (e.g. ... SGLT2 #Inhibitors #Pharmacology ... DM2 #diabetes #endocrinology
GLP-1 Agonists Adlyxin (Lixisenatide) Daily Bydureon (Exenatide ER) Weekly Ozempic (Semaglutide) Weekly Trulicity (Dulaglutide) Weekly Victoza (Liraglutide) Daily
Bydureon (Exenatide ER ... are subcutaneous injections ... GI tract) and injection ... GLP1 #Agonists #Pharmacology ... Diabetes #DM2 #Endocrinology
Coverage of common antibiotics used in the hospital For empiric coverage, first define the type of infection,
define the type of infection ... prior resistance. e.g ... ampicillin #management ... #antibiogram #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS Treating Visceral Leishmaniasis - Preferred Therapy: •
., 4 mg/kg on days ... dose of 20–60 mg/kg ... Prevention #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
A practical guide to starting levothyroxine therapy Calculate full replacement dose: 1.6 mcg/kg/day Young, otherwise healthy patient: •
dose: 1.6 mcg/kg ... initiation #starting #management ... #endocrinology ... #pharmacology #hypothyroidism
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS Preventing 1st Episode of Penicilliosis (Primary
Penicillium marneffei Infections ... Treating Acute Infection ... amphotericin B, 3 to 5 mg/kg ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19 IL-6 activates T cells and macrophages, among other cell types (see
Tocilizumab 4-8mg/kg ... respiratory tract infection ... Siltuximab 11mg/kg ... Siltuximab #COVID19 #Pharmacology ... #Management #Medications
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS Preventing Clinical Disease Indication: Individuals
Benznidazole 5–8 mg/kg ... Nifurtimox 8–10 mg/kg ... Prevention #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS Preventing CMV Disease: • CMV end-organ disease is best
Cytomegalovirus Infections ... other factors (e.g ... control of the infection ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
No results found for "ER ekg pharmacology medstudent infections management endocrinology"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #ER #ekg #pharmacology #medstudent #infections #management #endocrinology